Etoposide

Approved Uses

Etoposide is used to treat specific forms of cancer. It is often prescribed in combination with other chemotherapy medications to increase effectiveness. The primary conditions it is used for include:

• Small cell lung cancer: It is used as a first-line treatment for this type of lung cancer.
• Testicular cancer: It is used to treat testicular tumors that have not responded well to other treatments, surgeries, or radiation therapy.

This medication works by slowing or stopping the growth of cancer cells in the body. It may be administered either as an injection into a vein (intravenous) or as a capsule taken by mouth, depending on the specific type of cancer being treated and the treatment plan developed by a healthcare provider.

Mechanism of Action

Etoposide belongs to a class of medications known as podophyllotoxin derivatives. It works by interfering with the way cancer cells repair and copy their genetic material (DNA), which is necessary for the cells to divide and grow.

The medication works through several specific processes:

• Enzyme Inhibition: Etoposide blocks an enzyme called topoisomerase II. This enzyme is responsible for helping DNA uncoil and re-coil during cell division.
• DNA Damage: By blocking this enzyme, etoposide causes breaks in the DNA strands. When the DNA is damaged, the cancer cell receives a signal to stop dividing.
• Cell Death: If the damage to the DNA is severe enough, the cancer cell will eventually die.

Etoposide is most effective during specific phases of the cell cycle when cells are actively preparing to divide. Because cancer cells typically divide more frequently than most healthy cells, they are more likely to be affected by the medication. However, the drug can also impact healthy cells that divide quickly, such as those in the bone marrow or the lining of the digestive tract.

Common Side Effects

Many people experience side effects while taking etoposide. These often include:

• Nausea and vomiting
• Temporary hair loss
• Diarrhea or stomach pain
• Loss of appetite
• Mouth or throat sores
• General weakness or fatigue

Serious Side Effects

Some side effects can be severe and require immediate medical attention. Contact your healthcare provider right away if you experience:

• Signs of infection: Fever, chills, sore throat, or cough.
• Low blood cell counts: Unusual bruising, bleeding (such as nosebleeds or bleeding gums), or feeling extremely tired and pale.
• Allergic reactions: Rash, hives, itching, swelling of the face or throat, rapid heartbeat, or difficulty breathing.
• Nerve issues: Numbness, tingling, or a "pins and needles" sensation in the hands or feet.
• Vision changes: Sudden blurring or loss of vision.
• Injection site reactions: Pain, swelling, or redness where the medication was injected (for the intravenous form).

Bone Marrow Suppression

Etoposide can cause severe bone marrow suppression, leading to low counts of white blood cells, red blood cells, and platelets. This increases the risk of life-threatening infections and bleeding. Frequent blood counts are required during and after treatment to monitor for these effects.

Secondary Malignancies

There is an increased risk of developing secondary cancers, such as acute leukemia, following treatment with etoposide. This risk is present whether the drug is used alone or in combination with other chemotherapy treatments.

Hypersensitivity Reactions

Severe allergic reactions may occur, characterized by symptoms such as chills, fever, rapid heartbeat, difficulty breathing, and low blood pressure. These reactions often require stopping the infusion and receiving immediate medical treatment.

Administration Risks

Intravenous etoposide must be administered slowly, typically over 30 to 60 minutes, to prevent a sudden drop in blood pressure. It should not be given by rapid intravenous injection. Care must also be taken to avoid extravasation, which is the leaking of the drug into the surrounding tissue at the injection site.

Embryo-Fetal Toxicity

Etoposide can cause fetal harm if administered during pregnancy. Effective contraception is recommended for both men and women of reproductive potential during treatment and for a specified period after the final dose. The medication may also impact future fertility.

Liver and Kidney Impairment

Patients with existing liver or kidney disease may be at a higher risk for toxicity. Dosage adjustments may be necessary based on the severity of the impairment.

Pregnancy

Etoposide may cause serious harm to an unborn baby if used during pregnancy. Research indicates that the medication can cause birth defects or pregnancy loss. Healthcare providers typically advise against using this medication during pregnancy unless it is necessary for a life-threatening condition where safer alternatives are not available.

Individuals who can become pregnant should use effective birth control during treatment and for a specific period after the last dose. If a pregnancy occurs while taking this medication, the patient should immediately consult their healthcare provider to discuss the potential risks to the fetus.

Breastfeeding

It is not known whether etoposide passes into human breast milk. However, because of the potential for serious adverse reactions in a nursing infant, breastfeeding is generally not recommended during treatment. Patients should discuss with their healthcare provider whether to stop nursing or stop the medication.

Fertility

Etoposide may affect fertility in both men and women, which could impact the ability to have children in the future. Patients should discuss these risks and potential options with their medical team before starting treatment.

Available Forms

Etoposide is provided in several different formulations depending on the specific treatment plan and the condition being treated:

• Oral Capsules: These are liquid-filled capsules intended to be swallowed whole.
• Intravenous Injection: This is a concentrated solution that must be diluted by a healthcare professional before being administered through a vein as an infusion.
• Lyophilized Powder for Injection: This form consists of a sterile, freeze-dried powder that is reconstituted with a liquid solution by a healthcare provider before intravenous administration.

FDA Approval and Indications

Etoposide is approved by the U.S. Food and Drug Administration (FDA) for the treatment of the following conditions:

• Refractory Testicular Tumors: It is indicated for use in combination with other approved chemotherapeutic agents for patients who have already received appropriate surgical, chemotherapeutic, and radiotherapeutic therapy.
• Small Cell Lung Cancer: It is indicated as a first-line treatment in combination with other approved chemotherapeutic agents.

Boxed Warning

The FDA-approved labeling for etoposide includes a boxed warning regarding severe myelosuppression. This condition involves a significant decrease in bone marrow activity, resulting in low counts of white blood cells, red blood cells, and platelets. This can lead to an increased risk of life-threatening infections or bleeding complications. Healthcare providers must monitor blood counts frequently during treatment.

Regulatory Requirements for Administration

Due to its toxicity and the potential for severe side effects, the FDA requires that etoposide be administered under the supervision of a qualified physician experienced in the use of cancer chemotherapeutic agents. It is available in both oral capsule and intravenous injection formulations.

There are no specific Risk Evaluation and Mitigation Strategies (REMS) programs currently required for etoposide, but it is strictly regulated as a hazardous drug that requires specialized handling and disposal procedures to ensure the safety of healthcare workers and patients.

Factors Affecting Cost

The total expense for etoposide treatment is influenced by several variables related to its administration and the specific treatment plan:

• Administration Method: Etoposide is available as an injection for intravenous (IV) infusion and as oral capsules. The IV form is administered by healthcare professionals in a hospital or clinic, which may involve additional costs for the facility and professional services.
• Treatment Schedule: This medication is typically given in cycles, with doses administered over several consecutive days followed by a rest period. The total number of cycles required for treatment will impact the overall cost.
• Insurance Coverage: Coverage for etoposide depends on the individual's insurance plan, including Medicare or private health insurance. Patients should verify their specific benefits, including copayments or coinsurance requirements, with their provider.

Because etoposide is a potent chemotherapy drug, it may also require specialized handling or pharmacy services, which can influence the final cost.